1. FDA decision coming soon on Aimmune's contested peanut allergy drug — Roche's Tecentriq fails in bladder cancer trial — Pfizer launches biosims for Roche's 'big three' cancer drugs in the US — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Zulresso $519,000 in first 3 months

Discussion in 'Sage Therapeutics' started by anonymous, Oct 24, 2019 at 11:40 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest


  2. anonymous

    anonymous Guest

    I wasn’t expecting amazing sales with all the logistic issues and damn Sage central that sucks ass. But what concerns me is top leaders that say they need to keep our numbers secret when we are in a launch
     
  3. anonymous

    anonymous Guest

    Announced in 2Q earnings. Learn your industry.